These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23419589)

  • 1. Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children.
    Rodriguez L; Diaz J; Nurko S
    J Pediatr; 2013 Jul; 163(1):261-7. PubMed ID: 23419589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective review of cyproheptadine for feeding intolerance in children less than three years of age: effects and side effects.
    Merhar SL; Pentiuk SP; Mukkada VA; Meinzen-Derr J; Kaul A; Butler DR
    Acta Paediatr; 2016 Aug; 105(8):967-70. PubMed ID: 27194450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproheptadine Use in Children With Functional Gastrointestinal Disorders.
    Madani S; Cortes O; Thomas R
    J Pediatr Gastroenterol Nutr; 2016 Mar; 62(3):409-13. PubMed ID: 26308312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Therapy of Cyclic Vomiting Syndrome in Children: Comparison of Amitriptyline and Cyproheptadine: A Randomized Clinical Trial.
    Badihian N; Saneian H; Badihian S; Yaghini O
    Am J Gastroenterol; 2018 Jan; 113(1):135-140. PubMed ID: 28719594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System.
    Nguyen H; Pan A; Smollin C; Cantrell LF; Kearney T
    J Clin Pharm Ther; 2019 Apr; 44(2):327-334. PubMed ID: 30650197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial.
    Sadeghian M; Farahmand F; Fallahi GH; Abbasi A
    Minerva Pediatr; 2008 Dec; 60(6):1367-74. PubMed ID: 18971897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal migraine: prophylactic treatment and follow-up.
    Worawattanakul M; Rhoads JM; Lichtman SN; Ulshen MH
    J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):37-40. PubMed ID: 9890466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine.
    Andersen JM; Sugerman KS; Lockhart JR; Weinberg WA
    Pediatrics; 1997 Dec; 100(6):977-81. PubMed ID: 9374568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Predictors of Rapid Gastric Emptying in Patients Presenting with Dyspeptic Symptoms.
    Gomez Cifuentes J; Radetic M; Lopez R; Gabbard S
    Dig Dis Sci; 2019 Oct; 64(10):2899-2909. PubMed ID: 30982211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case study: cyproheptadine and aggression in a five-year-old boy.
    Strayhorn JM
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):668-70. PubMed ID: 9628088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.
    Marzio L; Cappello G; Grossi L; Manzoli L
    Dig Liver Dis; 2008 Mar; 40(3):188-93. PubMed ID: 18242155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric electrical stimulation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of delayed gastric emptying on the outcome of antireflux surgery.
    Bais JE; Samsom M; Boudesteijn EA; van Rijk PP; Akkermans LM; Gooszen HG
    Ann Surg; 2001 Aug; 234(2):139-46. PubMed ID: 11505058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome: early management with cyproheptadine.
    McDaniel WW
    Ann Pharmacother; 2001; 35(7-8):870-3. PubMed ID: 11485136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships.
    Cuomo R; Sarnelli G; Grasso R; Bruzzese D; Pumpo R; Salomone M; Nicolai E; Tack J; Budillon G
    Scand J Gastroenterol; 2001 Oct; 36(10):1030-6. PubMed ID: 11589374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia. Report of three cases.
    Cucchiara S; Minella R; Riezzo G; Vallone G; Vallone P; Castellone F; Auricchio S
    Dig Dis Sci; 1992 Jul; 37(7):1136-40. PubMed ID: 1618063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers.
    Zangen T; Ciarla C; Zangen S; Di Lorenzo C; Flores AF; Cocjin J; Reddy SN; Rowhani A; Schwankovsky L; Hyman PE
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):287-93. PubMed ID: 12960651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.